IBEX Pharmaceuticals Inc logo — Crafting the Future of Biomedical Enzymes with Unmatched Pur...

IBEX Pharmaceuticals Inc

Crafting the Future of Biomedical Enzymes with Unmatched Purity and Precision

Founded 1987 18 employees Biotechnology, Health Care

General Information

Company Name IBEX Pharmaceuticals Inc
Founded Year 1987
Employees 18
Industries Biotechnology, Health Care
Social

Get notified when IBEX Pharmaceuticals Inc moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About IBEX Pharmaceuticals Inc

IBEX Pharmaceuticals Inc, established in 1987, is a Canadian company pioneering the production and marketing of enzymes for biomedical applications. The company's slogan "Crafting the Future of Biomedical Enzymes with Unmatched Purity and Precision" encapsulates its commitment to innovation and quality. IBEX's portfolio includes a diverse range of highly pure recombinant glycosaminoglycan (GAG) lyases, such as Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B, tailored to meet specific biomedical needs. Additionally, IBEX manufactures arthritis assays used in pharmaceutical research, further diversifying its product offerings. The company's utilization of a proprietary expression system in Flavobacterium heparinum ensures that its enzymes achieve the highest levels of purity and precision, enhancing their effectiveness in biomedical applications. Notably, Heparinase I is distinguished for its unique ability to neutralize both unfractionated and low molecular weight heparin, enabling accurate monitoring of baseline hemostasis in the presence of these anticoagulants. IBEX Technologies Inc operates within the Biotechnology and Health Care industries, positioning itself at the intersection of cutting-edge biotech advancements and crucial healthcare needs. Currently, the company's headquarters location is not specified. However, with its specialized expertise and innovative product offerings, IBEX Pharmaceuticals Inc stands as a compelling prospect for potential investment from venture capitalists seeking to support groundbreaking advancements in the biomedical field.

Taxonomy: Biomedical enzymes, Enzyme production, Recombinant glycosaminoglycan lyases, Heparinase, Chondroitinase, Arthritis assays, Pharmaceutical research, Biomedical applications, Purity levels, Flavobacterium heparinum, Canada-based company, Proprietary expression system, Anticoagulants, Biomedical technology, Hemostasis monitoring

No funding data available for IBEX Pharmaceuticals Inc yet.

Get notified when IBEX Pharmaceuticals Inc raises funding

IBEX Pharmaceuticals Inc Alternatives & Competitors

IBEX Pharmaceuticals Inc vs

Advancing the future of tumor treatment through innovative research and application in immunotherapy...

Seed
11-50 employees
Biotechnology
IBEX Pharmaceuticals Inc vs

Biomedical research to improve human health.

867 employees
Social Media
IBEX Pharmaceuticals Inc vs

The JCI is the publication of the American Society for Clinical Investigation, an honor society of p...

28 employees
Publishing

FAQ About IBEX Pharmaceuticals Inc

Crafting the Future of Biomedical Enzymes with Unmatched Purity and Precision
IBEX Pharmaceuticals Inc was founded in 1987.
IBEX Pharmaceuticals Inc operates in the following industries: Biotechnology, Health Care.
IBEX Pharmaceuticals Inc has approximately 18 employees.
Top alternatives and competitors to IBEX Pharmaceuticals Inc include Immupeutics Medicine, RI-MUHC | Research Institute of the MUHC | #rimuhc, The Journal of Clinical Investigation, Bivision, LifeMap Sciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
IBEX Pharmaceuticals Inc and Immupeutics Medicine are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors IBEX Pharmaceuticals Inc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy